Observational Study of Type 1 Diabetics Switching From Human Insulins to Modern Insulin Analogues

A Prospective, Multicentre, Open Label, Non-controlled, Observational, 24-week Study in Patients Using NovoRapid® (Insulin Aspart) and Levemir® (Insulin Detemir) in a Basal-bolus Regimen for Treatment of Type 1 Diabetes Mellitus in Romania

This trial is conducted in Europe. The aim of this observational study is to evaluate the blood glucose control (HbA1c) using NovoRapid® (insulin aspart) and Levemir® (insulin detemir) after switch from human insulins for treatment of type 1 diabetes under normal clinical practice conditions in Romania.

Inclusion Criteria:

• Any subject with type 1 diabetes who is treated with human rapid and intermediate (NPH) insulin in basal-bolus regimen

Exclusion Criteria:

• Subjects currently being treated with insulin aspart and insulin detemir
• Subjects who were previously enrolled in this study
• Subjects with a hypersensitivity to insulin aspart or to any of the excipients
• Subjects with a hypersensitivity to insulin detemir or to any of the excipients
• Women who are pregnant or have the intention of becoming pregnant within next 6 months